Epigenomics AG (EPGNF)
1.12
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Epigenomics EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -3.358 |
| March 31, 2023 | -7.031 |
| December 31, 2022 | -8.108 |
| September 30, 2022 | -1.920 |
| June 30, 2022 | -1.693 |
| March 31, 2022 | -3.730 |
| December 31, 2021 | -2.555 |
| September 30, 2021 | 3.743 |
| June 30, 2021 | -5.025 |
| March 31, 2021 | -4.816 |
| December 31, 2020 | -10.23 |
| September 30, 2020 | -10.72 |
| June 30, 2020 | -12.37 |
| March 31, 2020 | -11.84 |
| December 31, 2019 | -31.05 |
| September 30, 2019 | -12.23 |
| June 30, 2019 | -20.95 |
| March 31, 2019 | -14.53 |
| December 31, 2018 | -19.09 |
| September 30, 2018 | -20.52 |
| June 30, 2018 | -18.66 |
| March 31, 2018 | -22.76 |
| December 31, 2017 | -18.45 |
| September 30, 2017 | -8.367 |
| June 30, 2017 | -28.24 |
| Date | Value |
|---|---|
| March 31, 2017 | -15.18 |
| December 31, 2016 | -7.676 |
| September 30, 2016 | -17.49 |
| June 30, 2016 | -25.74 |
| March 31, 2016 | -36.12 |
| December 31, 2015 | -7.796 |
| September 30, 2015 | -22.17 |
| June 30, 2015 | -23.64 |
| March 31, 2015 | -31.95 |
| December 31, 2014 | -37.27 |
| September 30, 2014 | -26.36 |
| June 30, 2014 | -25.33 |
| March 31, 2014 | -33.10 |
| December 31, 2013 | -32.88 |
| September 30, 2013 | -30.11 |
| June 30, 2013 | -25.97 |
| March 31, 2013 | -30.02 |
| December 31, 2012 | -54.11 |
| September 30, 2012 | -68.46 |
| June 30, 2012 | -63.51 |
| March 31, 2012 | -46.15 |
| December 31, 2011 | -96.61 |
| September 30, 2011 | -101.22 |
| June 30, 2011 | -65.67 |
| March 31, 2011 | -62.45 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CureVac NV | 1.414 |
| PAION AG | -- |
| Anbio Biotechnology | -- |
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | -2.521M |
| Earnings Yield | -27.75% |
| Normalized Earnings Yield | -27.26 |